Panbela to Participate in Upcoming Virtual Investor Conferences
Panbela Therapeutics, Inc. (PBLA)
Company Research
Source: GlobeNewswire
MINNEAPOLIS, March 08, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced management will participate in three upcoming virtual investor conferences: H.C. Wainwright Global Life Sciences Conference: March 9-10, 202133rd Annual ROTH Conference: March 15-17, 2021Maxim Emerging Growth Conference: March 17-18, 2021 For more information or to schedule a one-on-one meeting with management, please contact your conference representative or James@HaydenIR.com. About SBP-101 SBP-101 is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma and other tumors. The molecule has shown signals of tumor growth inhibition in clinical studies of US and Australian metastatic pancreatic cancer patients, suggesting p
Show less
Read more
Impact Snapshot
Event Time:
PBLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBLA alerts
High impacting Panbela Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PBLA
News
- Panbela Announces Poster Presentation at American Association for Cancer Research: [Yahoo! Finance]Yahoo! Finance
- Panbela Announces Poster Presentation at American Association for Cancer Research:GlobeNewswire
- Panbela Announces Transfer to OTCQB MarketGlobeNewswire
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.MarketBeat
- Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
PBLA
Earnings
- 3/26/24 - Miss
PBLA
Sec Filings
- 4/18/24 - Form S-1
- 4/17/24 - Form 8-K
- 4/17/24 - Form EFFECT
- PBLA's page on the SEC website